🇮🇳India·March 22, 2026·daily

India NCLT Insolvency Resolution Filings — March 22, 2026

Tayo Rolls Limited (504961) remains entrenched in Corporate Insolvency Resolution Process (CIRP) initiated on October 30, 2019, marking over 6 years of insolvency proceedings with no resolution implementation. NCLT approved JBVNL's acquisition resolution plan on December 17, 2024, but NCLAT stay has stalled progress, leading to a deadlock in quarterly and annual statutory compliances for periods ended March 31, 2025. The erstwhile Compliance Officer, Harpreet Kaur Bhamra, has flagged inaction by the Successful Resolution Applicant (JBVNL) and Resolution Professional M. Anish Agarwal, requesting exemptions for key managerial personnel amid inoperative email and website. Sentiment is strongly negative with high materiality (9/10), signaling severe operational paralysis and regulatory uncertainty. No period-over-period financial trends available due to insolvency status, but prolonged CIRP highlights deteriorating governance and compliance trends versus resolved peers. Market implications include heightened illiquidity risk, potential delisting, and zero shareholder value until resolution, underscoring broader IBC delays in manufacturing sector.

1 high priority1 total filings

🇮🇳India·March 22, 2026·daily

India MCA Insolvency Liquidation Filings — March 22, 2026

The India MCA Insolvency & Restructuring Monitor highlights a single high-materiality (9/10) development in Tayo Rolls Limited, a steel rolls manufacturer under prolonged CIRP since October 30, 2019, with NCLT approval of JBVNL's resolution plan on December 17, 2024, stalled by NCLAT stay, leading to compliance deadlocks for FY ended March 31, 2025. No period-over-period financial trends available due to insolvency suspension, but ongoing inaction by RP M. Anish Agarwal and Successful Resolution Applicant JBVNL has rendered email/website inoperative, exacerbating statutory non-compliance. Negative sentiment dominates amid erstwhile Compliance Officer Harpreet Kaur Bhamra's plea for KMP liability exemption, signaling governance paralysis over 6+ years of CIRP. Market implications include heightened delisting/suspension risks for stock code 504961, with repeated BSE representations (April 6, 2019; December 18, 2024; May 30, 2025) underscoring persistent unresolved issues. Portfolio-level pattern: Isolated but emblematic of extended IBC delays in manufacturing sector, potentially pressuring creditor recoveries and investor confidence.

1 high priority1 total filings

🇮🇳India·March 21, 2026·daily

India NCLT Insolvency Resolution Filings — March 21, 2026

The India Corporate Insolvency & NCLT stream reveals heightened distress in smaller listed companies, with Radhagobind Commercial Limited's ongoing CIRP featuring a 5th CoC meeting on March 21, 2026, and no resolution plans approved despite deadline extensions to March 17, 2026 midnight, signaling prolonged uncertainty. Remedium Lifecare Limited faces fresh NCLT admission on March 17, 2026, for a ₹7.47 Cr operational debt default (principal ₹6.19 Cr + interest ₹1.28 Cr at 18% p.a. from Nov 7, 2023), imposing a Section 14 moratorium. In contrast, Delhivery Limited secured positive NCLT approval on March 20, 2026, for merging loss-making subsidiaries (SLPL negative reserves ₹-12 Cr) into its robust ₹11,843 Cr equity base as of Dec 31, 2024, aiming for operational streamlining. Adani Power and Larsen & Toubro report neutral investor/media events on March 24 and March 21, 2026, respectively, with no UPSI or financial disclosures. No explicit YoY/QoQ trends across filings, but insolvency cases dominate (3/6 filings, 100% negative sentiment), underscoring portfolio risks in commercial, healthcare, and logistics sectors versus stability in power/infra giants. Market implications include potential delisting/wipeout for insolvents and efficiency gains for Delhivery.

3 high priority3 medium6 total filings

🇮🇳India·March 21, 2026·daily

India MCA Insolvency Liquidation Filings — March 21, 2026

Three filings underscore escalating insolvency distress in Indian small-cap listed entities, with all exhibiting negative sentiment and maximum materiality (10/10). Radhagobind Commercial Limited (BSE:030070, CSE:539673) features in two updates, progressing from IRP appointment (Oct 30, 2025) and RP confirmation (Jan 27, 2026) to its 5th COC meeting on March 21, 2026, where CIRP costs, late resolution plans (up to March 17 midnight), and interim finance needs were discussed without resolution progress. Remedium Lifecare Limited faces fresh CIRP admission by NCLT Mumbai (March 17, 2026) on a ₹7.47 Cr operational debt default (principal ₹6.19 Cr post ₹12.17 Cr payments on ₹18.36 Cr invoices, plus ₹1.28 Cr interest at 18% p.a. from Nov 7, 2023 default), triggering moratorium under IBC Section 14. No period-over-period financial trends, insider activity, capital allocation, or positive guidance disclosed across filings, highlighting stalled operations and creditor dominance. Portfolio-level pattern: 100% negative outcomes, prolonged timelines (Radhagobind ~5 months to 5th COC; Remedium 2.5 years from default to admission), implying shareholder value erosion, trading suspensions, and liquidation risks. Market implications: Bearish for holdings, alpha in shorts or distressed debt plays.

3 high priority3 total filings

🇮🇳India·March 20, 2026·daily

India NCLT Insolvency Resolution Filings — March 20, 2026

Across 20 filings in the India Corporate Insolvency & NCLT stream, a bifurcated landscape emerges: 8 insolvency-related updates show mixed progress with 3 positive resolutions/dismissals (Zee Learn, Trustwave, Fenoplast withdrawal) offsetting ongoing CIRP delays and new applications (Baron Infotech 20th CoC, Heranba ₹2.63Cr claim), while 12 non-insolvency company updates are predominantly positive (10/12 bullish/neutral), highlighting board enhancements, investments, and AI partnerships in IT/logistics/auto sectors. Key period-over-period trend: Optare (Ashok Leyland sub) revenue surged 74% YoY to ₹1,233Cr in FY24-25 from ₹707Cr, following 208% prior YoY, signaling strong recovery outlier vs stagnant peers. Critical developments include NCLT extensions (Oberoi Realty to May 7, 2026) and CoC meetings (Baron, AGS, Quadrant), implying prolonged uncertainty in insolvencies; positive ESOP allotments across banks/IT (Wipro, ICICI, Yes Bank) indicate stable capital allocation with minimal dilution (<0.01% paid-up). Portfolio-level patterns: Insolvency cos average materiality 8/10 with negative/mixed sentiment (6/8), contrasting bullish non-insolvency (avg materiality 6/10); no insider trading or dividend/buyback activity noted, but capital reductions (Trustwave -90% equity to offset ₹6.21Cr losses) and investments (Ashok Leyland ₹375Cr) reveal deleveraging/reinvestment themes. Market implications: Opportunities in post-resolution rebounds (e.g., Zee Learn), risks in protracted CIRPs dragging valuations.

9 high priority11 medium20 total filings

🇮🇳India·March 20, 2026·daily

India MCA Insolvency Liquidation Filings — March 20, 2026

Across the 8 filings in the India MCA Insolvency & Restructuring Monitor, dominant themes include prolonged Corporate Insolvency Resolution Processes (CIRP) for 4 companies (Baron Infotech, AGS Transact, Quadrant Televentures, with multiple CoC meetings), a new Section 9 IBC petition against Heranba Industries for ₹2.63 Cr, delayed implementation of Oberoi Realty's ₹919.25 Cr resolution acquisition despite NCLT approval, positive petition dismissal for Zee Learn, NCLT-approved capital reduction for Trustwave Securities to offset ₹6.21 Cr losses, and Fenoplast's withdrawal of equity reduction record date post-resolution plan. No period-over-period financial comparisons (YoY/QoQ revenue, margins, ratios) or operational metrics disclosed in any filing, limiting quantitative trend analysis to procedural timelines; e.g., Baron at 20th CoC vs AGS at 9th indicates varying process maturity. Critical developments cluster around imminent CoC meetings (March 23 for Baron/Quadrant) and NCLT hearing (Heranba April 20), signaling potential resolution catalysts amid 6/8 negative/neutral sentiments. Portfolio-level pattern: 50% filings show ongoing CIRP delays (avg 6-18 months inferred from meeting counts), heightening volatility for listed scrips; acquirers like Oberoi present turnaround opportunities while vendors like Haresh Petrochem flag supplier risks. Market implications: Watch for resolution plan approvals to unlock value in distressed assets, but possession delays and small claims could pressure ops.

8 high priority8 total filings

🇮🇳India·March 19, 2026·daily

India NCLT Insolvency Resolution Filings — March 19, 2026

The 'India Corporate Insolvency & NCLT' stream reveals a surge in resolution activity with NCLT approvals for Rajeswari Infrastructure (Jan 13, 2026) and Jaiprakash Associates (Mar 17, 2026, claims ₹57,497 Cr), highlighting Adani Group's aggressive acquisition of distressed infra/aviation/power/fertilizer assets via resolution plans, positioning them for portfolio expansion. Ongoing CIRPs dominate with prolonged processes (e.g., JCT's 13th CoC meeting Mar 20, Compuage's 24th Mar 25, Ansal's 50th Mar 23), signaling persistent distress in infra/realty/textiles/IT hardware sectors amid multiple extensions. New CIRP admission for Supha Pharmachem (Mar 17, 2026, default ₹7.47 Cr) adds to pharma distress. Sparse period trends show ONGC's production declining mildly (FY25 -1.68% YoY to 41.08 MMTOE, 9MFY26 -0.55% YoY) but margins expanding (13.4% FY25 to 15.9% 9MFY26), with AAA rating affirmed. Positive non-insolvency updates include Adani's rights issue conversion (13.74 Cr shares), Wipro's GIFT City AI hub (150-500 seats), TCS partnerships, and Bharat Coking Coal's record 2.36L tonne booking. Market implications: Bullish for Adani ecosystem on cheap asset grabs, bearish for equity holders in CIRPs (e.g., Jaiprakash delisting at NIL), with catalysts in near-term CoC meetings and ONGC's Daman project (Mar-Apr 2026). Portfolio pattern: 9/20 filings insolvency-related, with Adani-linked positives offsetting distress.

11 high priority9 medium20 total filings

🇮🇳India·March 19, 2026·daily

India MCA Insolvency Liquidation Filings — March 19, 2026

Across the 11 filings in the India MCA Insolvency & Restructuring Monitor, dominant themes include resolution plan approvals concluding CIRPs for Rajeswari Infrastructure and Jaiprakash Associates (led by Adani Enterprises), signaling Adani group's aggressive expansion into aviation, power, and fertilizer assets amid ₹57,497.93 Cr admitted claims; contrasted by new CIRP admissions (Supha Pharmachem for ₹7.47 Cr default) and prolonged proceedings with multiple CoC meetings (JCT's 13th upcoming, Compuage's 24th, Ansal's 50th). No explicit YoY/QoQ financial trends available, but procedural extensions (e.g., Rajeswari's 6+ CoC extensions totaling 330+ days) highlight chronic distress in infra, pharma, and realty sectors. Positive outlier: Bharat Coking Coal's record 2,36,850-tonne single-day coal booking under discount scheme. Market implications favor Adani ecosystem for asset acquisitions at haircuts (e.g., JAL equity NIL, unsecured creditors NIL), while ongoing CIRPs pose delisting/zero-recovery risks for equity holders. Portfolio-level pattern: 5/11 filings show active CoC meetings this week (Mar 20-25, 2026), building to potential catalysts.

8 high priority3 medium11 total filings

🇮🇳India·March 18, 2026·daily

India NCLT Insolvency Resolution Filings — March 18, 2026

Across 18 filings in the India Corporate Insolvency & NCLT stream, key themes include advancing CIRP proceedings in distressed firms like Bloom Dekor and Quadrant Televentures seeking extensions and meetings, contrasted by positive restructuring approvals at Gabriel India (99.99% shareholder vote) and operational expansions in aviation/logistics (IndiGo land allotment, Delhivery international launch). Period-over-period trends highlight IndiGo's sharp PAT decline to ₹143 Cr in 9MFY2026 from ₹7,258 Cr FY2025 amid geopolitical/oil pressures, with no broad revenue/margin compression patterns across portfolio due to diverse updates. Insolvency-related filings (4/18) dominate high materiality (avg 9/10), signaling ongoing resolution risks, while IT/banking show neutral/positive catalysts like awards and redemptions. Capital allocation leans conservative with note redemptions (ICICI USD 816M), share allotments (ITC 0.019% dilution), and upcoming dividends (TVS Mar 24, ICICI Apr 18). Portfolio-level pattern: 3/18 filings flag scheduled events in next week (Quadrant COC Mar 20, TVS board Mar 24), creating near-term volatility; bullish restructuring offsets bearish insolvency drags, favoring selective longs in approved schemes.

7 high priority11 medium18 total filings

🇮🇳India·March 18, 2026·daily

India MCA Insolvency Liquidation Filings — March 18, 2026

The India MCA Insolvency & Restructuring Monitor highlights mixed developments across 4 filings: prolonged CIRP proceedings in Bloom Dekor Limited (21st COC meeting seeking 120-day extension) and Quadrant Televentures Limited (7th COC on March 20, 2026), signaling ongoing distress with negative sentiment, contrasted by Gabriel India Limited's near-unanimous (99.99%) shareholder approval for a composite scheme of amalgamation and demerger on March 18, 2026, marking a positive restructuring milestone. No explicit period-over-period financial comparisons (YoY/QoQ revenue, margins) or operational metrics were disclosed in these procedural filings, limiting quantitative trend analysis, but procedural unanimity in Bloom's COC (100%) and Gabriel's voting (promoters 100%, public 99.99%) indicates strong stakeholder alignment where present. Critical implications include heightened liquidation risks in extended CIRPs (Bloom, Quadrant), potential value unlock via Gabriel's scheme post-NCLT sanction, and portfolio-level stress in 2/4 filings (50%) with negative sentiment and high materiality (9/10). Forward-looking catalysts cluster around March 2026 COC meetings and NCLT approvals, with no insider trading, capital allocation (dividends/buybacks), or M&A valuations detailed. Overarching theme: Selective restructuring successes amid persistent insolvency drags, favoring opportunistic plays in approved schemes over open CIRPs.

4 high priority4 total filings

🇮🇳India·March 17, 2026·daily

India NCLT Insolvency Resolution Filings — March 17, 2026

Across 28 filings in the India Corporate Insolvency & NCLT stream, dominant themes include accelerating NCLT approvals for amalgamations (e.g., Lyka Labs, Mercantile Ventures/India Radiators, Shilpa Medicare) and resolution plans (Adani Enterprises for Jaiprakash Associates), alongside ongoing CIRP proceedings for distressed firms like Telephone Cables Limited and Videocon group entities. Positive developments feature unanimous shareholder/creditor approvals (100% in 4/5 merger votes) and strategic acquisitions via CIRP (Sumeet Industries at ₹23.47 Cr), signaling consolidation opportunities, while bearish signals emerge from shareholder wipeouts (Jaiprakash Associates/Power Ventures: NIL consideration, full delisting) and prolonged insolvencies (Telephone Cables: ₹1,806 Cr default, CIRP to Aug 2026). Limited period-over-period financial trends show Maruti Suzuki's robust FY24-25 production +6% YoY to 2.1M units and 9M FY25-26 sales +8.6% YoY to ₹1,349 Bn, contrasting with insolvency cases lacking recovery metrics. Portfolio-level patterns indicate 7/28 filings (25%) with positive resolution progress vs. 6/28 (21%) deepening distress, with Adani group's aggressive CIRP bids as a key market mover. Non-insolvency updates (Wipro/TCS partnerships, allotments) add neutral operational noise, but insolvency catalysts dominate actionable intelligence for distressed asset plays.

14 high priority14 medium28 total filings

🇮🇳India·March 17, 2026·daily

India MCA Insolvency Liquidation Filings — March 17, 2026

The India MCA Insolvency & Restructuring Monitor reveals a surge in NCLT-driven resolutions and amalgamations, with 6/15 filings (40%) reporting approvals or unanimous votes for schemes (Lyka Labs, Mercantile Ventures/India Radiators, Shilpa Medicare), signaling accelerated restructuring momentum. Critical developments include CIRP commencement for Telephone Cables Limited (₹1,806.57 Cr default as on 30.04.2024, non-operational since ~2015), Adani Enterprises' oral approval for Jaiprakash Associates resolution plan (NIL shareholder consideration, delisting), and Sumeet Industries' ₹23.47 Cr acquisition of Nakoda's 400 TPD polyester plant. Portfolio-level patterns show long-distressed assets (decade+ inactivity in Telephone Cables) shifting to CIRP post-failed liquidations, with no asset sales yet; aggregate distressed debt exposure ~₹1,830 Cr across highlighted cases. No broad YoY/QoQ revenue trends due to insolvency focus, but operational declines noted (e.g., failed plant sales, loss-making subsidiaries). Implications: Bearish for existing shareholders (wipeouts in Jaiprakash group), bullish for acquirers like Adani/Sumeet; watch for implementation catalysts amid neutral-to-negative sentiment (9/15 negative/neutral). First 8 filings highlight fresh CIRP/amalgamation activity.

14 high priority1 medium15 total filings

🇮🇳India·March 16, 2026·daily

India NCLT Insolvency Resolution Filings — March 16, 2026

Across 13 filings in the India Corporate Insolvency & NCLT stream, a dominant theme is NCLT approvals for restructuring schemes, with 5 key positive sanctions (Prima Plastics, Arkade Developers, Adani Enterprises, Bhagyanagar India, Adani Tradecom) signaling streamlined operations and value unlocking, particularly in real estate and conglomerates. Prolonged insolvency risks persist, highlighted by Quadrant Televentures' 90-day CIRP extension to May 30, 2026, and Talwalkars' liquidation update, contrasting with unanimous creditor approvals like Bhagyanagar's 100% (₹285 Cr value). Non-insolvency updates show mixed corporate momentum: RIL's US$3B+ green ammonia deal from H2 FY2029 bullish for new energy, Tata Motors' 1.5% price hike from April 1, 2026 to offset costs (mixed), minor Airtel penalty (₹8L), and IDBI Bank's disinvestment uncertainty. No broad period-over-period trends emerge due to filing diversity, but net worth infusions (e.g., Arkade's ₹1,260.55L turning Filmistan positive) and overwhelming approvals (Adani 99.9998%) indicate improving financial health in restructurings. Market implications favor restructuring plays for near-term catalysts like effective dates, while flagging extended CIRPs as value traps. Portfolio-level pattern: 6/13 filings positive sentiment, clustered around March 16, 2026 NCLT orders.

5 high priority8 medium13 total filings

🇮🇳India·March 16, 2026·daily

India MCA Insolvency Liquidation Filings — March 16, 2026

Across the 6 filings in the India MCA Insolvency & Restructuring Monitor (Mar 16, 2026), NCLT sanctions dominated with 4 schemes of arrangement/amalgamations/demergers approved (Prima Plastics, Arkade Developers, Adani Enterprises, Bhagyanagar India), signaling strong restructuring momentum and near-unanimous approvals (e.g., Adani 99.9998%, Bhagyanagar 100% on ₹285.04 Cr creditors). Positive sentiments prevailed in 3/6 cases, contrasting sharp negatives in ongoing CIRP extensions (Quadrant Televentures +90 days to May 30, 2026) and liquidation updates (Talwalkars). No broad YoY/QoQ revenue or margin trends emerged, but key period snapshots showed net worth turnarounds (Arkade infused ₹1,260.55 L Sep 26, 2025, flipping Filmistan from negative as of Mar 31, 2025); Adani's net worth robust at pre-scheme levels. Portfolio-level pattern: 4/6 companies advancing to effective stages post-sanction, unlocking operational efficiencies and synergies, while 2/6 face prolonged distress. Market implications include near-term catalysts from RoC filings for effective dates, potential value unlocks in realty/green energy (Arkade/Adani), and heightened risks in fitness/telecom insolvencies.

5 high priority1 medium6 total filings

🇮🇳India·March 15, 2026·daily

India NCLT Insolvency Resolution Filings — March 15, 2026

Across the two filings in the India Corporate Insolvency & NCLT stream, no direct insolvency or NCLT proceedings are noted, signaling stable operations for large-cap leaders Infosys (IT) and Adani Power (energy/utilities). Adani Power demonstrates robust growth with its fifth PSA win in FY25-26, adding 1,600 MW long-term supply (25-year term from FY2030-31 at ₹5.30/kWh), boosting tied-up capacity to 13.3 GW (out of 23.8 GW pipeline) and 95% of 18.15 GW operating capacity secured under PSAs, with ambitious expansion to 41.87 GW by FY31-32 via ₹2,00,000 Cr capex. Infosys announces a routine board meeting on April 22-23, 2026, for Q4/FY26 audited results (INDAS/IFRS) and potential final dividend, alongside an investor call on April 23 for business outlook, with trading window closed from March 16 to April 27 per SEBI insider trading rules. Period-over-period insights are limited, but Adani's FY25-26 PSA wins (10,400 MW total) indicate YoY order momentum acceleration versus prior years' pipeline development. Neutral sentiment for Infosys contrasts positive for Adani, highlighting sector divergence; no insider transactions, pledges, or capital allocation shifts (beyond potential dividend) reported, but forward-looking catalysts dominate. Market implications include alpha from Adani's revenue visibility and Infosys pre-earnings positioning, with no portfolio-level distress patterns.

1 high priority1 medium2 total filings

🇮🇳India·March 14, 2026·daily

India NCLT Insolvency Resolution Filings — March 14, 2026

Across 11 filings in the India Corporate Insolvency & NCLT stream, 7 (64%) report positive outcomes including disposed insolvencies, unanimous scheme approvals >99%, and NCLT approvals, signaling strong resolution momentum in hospitality, finance, metals, and renewables. Key positives include Sayaji Hotels' full disposal, Share India Securities' 99.825% equity approval (63.178% turnout on 218.83M shares), Bhagyanagar India's requisite majority approvals, and Inox Green Energy's demerger sanction. Contrasts include Tijaria Polypipes' new Bank of India petition (listing April 10) and mixed cases like Embassy Developments' stayed CIRP (adjourned March 19) and IndiGo's Middle East suspensions till March 28. Adani Ports expanded to 633 MTPA (28% India port volumes) with 1B tonne target by 2030, a forward outlier. No aggregate YoY/QoQ financial declines noted, but scheme approvals imply stabilizing balance sheets vs distress initiations; portfolio trend favors restructuring plays with 70%+ positive materiality >8/10.

8 high priority3 medium11 total filings

🇮🇳India·March 14, 2026·daily

India MCA Insolvency Liquidation Filings — March 14, 2026

Across 8 filings in the India MCA Insolvency & Restructuring Monitor, 6/8 show positive resolutions including disposed insolvency petitions, unanimous scheme approvals for amalgamations/demergers, signaling successful restructurings and reduced distress risks. Key themes include amicable settlements (Sayaji Hotels) and overwhelming stakeholder approvals (Share India Securities 99.825%, Bhagyanagar India, Inox Green Energy near-100%), contrasting with one new high-materiality insolvency petition (Tijaria Polypipes) and one mixed ongoing NCLAT stay (Embassy Developments). No period-over-period financial trends available, but event timelines indicate acceleration in Q1 2026 resolutions vs prior 2025 filings. Portfolio-level pattern: Restructuring via NCLT schemes dominates over liquidations, with 100% approval rates in creditor meetings pointing to financial stability restoration. Market implications favor bullish positioning in approved entities for value unlock, while flagging isolated distress in polypipes/manufacturing. Overall sentiment skews positive (75%), enhancing investor confidence in IBC process efficiency.

8 high priority8 total filings

🇮🇳India·March 13, 2026·daily

India NCLT Insolvency Resolution Filings — March 13, 2026

Across 20 filings in the India Corporate Insolvency & NCLT stream, key themes include advancing NCLT-mandated schemes of amalgamation (Mercantile Ventures/India Radiators, Dabur/Sesa Care) and insolvency resolutions (Punj Lloyd preferential to Adani, Garodia Chemicals capital restructure), with procedural shareholder meetings completed on March 13, 2026, signaling progress toward resolutions. Garodia faces severe public shareholder dilution (92% cancellation), while Shree Hanuman's 16th CoC meeting underscores prolonged CIRP. Non-insolvency positives feature Jio Financial's reinsurance JV license, Tata Motors' 5,000+ bus orders, Bondada's ₹35.4 Cr orders, and BlackRock's stake hike in Sammaan Capital; IndiGo cites 85% fuel surge prompting charges amid strong ops (400+ fleet, 124M CY25 customers). No broad period-over-period financial trends disclosed (e.g., YoY revenue/margins absent across filings), but forward-looking catalysts cluster around March 17-25 (CoC, record dates, board meetings). Portfolio-level pattern: 6/20 filings tied to insolvency resolutions show mixed outcomes (3 positive strategic shifts vs 2 equity-eroding), implying selective alpha in Adani-linked turnarounds amid neutral procedural momentum. Market implications: Monitor NCLT outcomes for delisting/relisting risks; bullish on operational wins offsetting fuel/geopolitical pressures.

11 high priority9 medium20 total filings

🇮🇳India·March 13, 2026·daily

India MCA Insolvency Liquidation Filings — March 13, 2026

Across 9 filings in the India MCA Insolvency & Restructuring Monitor, dominant themes include NCLT-directed amalgamations (Dabur-Sesa, Mercantile-India Radiators), capital restructuring under insolvency (Garodia 92% public share cancellation, Punj Lloyd preferential issuance), and ongoing CIRP proceedings (Shree Hanuman 16th CoC meeting). No explicit period-over-period financial trends disclosed in procedural filings, but positive synergies noted in Dabur's merger contrast with negative dilutions in Garodia; neutral procedural updates dominate Mercantile and India Radiators meetings. Critical developments flag turnaround potential in Adani-linked Punj Lloyd issuance and Dabur portfolio enhancement, while Garodia's BRP execution poses severe dilution risk to public holders. Portfolio-level patterns show 4/9 filings tied to amalgamations (progressing since Apr 2025), 2/9 with capital reductions/issuances, and prolonged CIRP in sugar/chemicals sectors. Market implications: Heightened volatility around record dates and voting outcomes, with alpha in merger completions vs risks in equity wipes.

9 high priority9 total filings

🇮🇳India·March 12, 2026·daily

India NCLT Insolvency Resolution Filings — March 12, 2026

Across the 13 filings in the India Corporate Insolvency & NCLT stream, a dominant theme is progress in insolvency and restructuring proceedings, with 4 high-materiality updates (Scan Projects merger petition, Punj Lloyd preferential issuance to Adani, Accel NCLT-approved amalgamation, AGS Transact CoC meeting) signaling resolution advancements amid CIRP distress. Non-insolvency filings highlight debt management (Adani Ports tender accepting $199.57M notes, short of caps), capacity expansions (Infosys Mohali to 3,000 seats from 1,000), and product launches (TVS Orbiter EV at ₹49,999 with BaaS), with neutral/mixed sentiments prevailing (8/13 neutral/mixed). No explicit aggregate YoY/QoQ financial trends available, but qualitative period comparisons show insolvency timelines accelerating (e.g., Punj Lloyd post-Feb 2026 NCLT orders, Accel effective from Apr 2024). Critical developments include Adani's limited tender uptake indicating cautious debt reduction, and positive synergies in Accel merger; market implications favor turnaround plays in insolvency names but flag prolonged CIRP risks like AGS. Portfolio-level pattern: 3/7 insolvency-related filings (new+context) show NCLT/CoC momentum, contrasting routine IR in healthy firms (Airtel, Maruti).

4 high priority9 medium13 total filings